title: [Treatment of hyperlipidemia in the prevention of ischemic heart disease. A proposal for the unification of medical management. I and II].
authors.forename: H
authors.initials: H
authors.lastname: Adamska-Dyniewska
authors.forename: J
authors.initials: J
authors.lastname: Chojnowska-Jezierska
authors.forename: B
authors.initials: B
authors.lastname: Cybulska
authors.forename: J
authors.initials: J
authors.lastname: Dzieniszewski
authors.forename: L
authors.initials: L
authors.lastname: Hryniewiecki
authors.forename: B
authors.initials: B
authors.lastname: Idzior-Waluś
authors.forename: I
authors.initials: I
authors.lastname: Jabłońska-Kaszewska
authors.forename: A
authors.initials: A
authors.lastname: Jaszcz-Kanecka
authors.forename: L
authors.initials: L
authors.lastname: Kłosiewicz-Latoszek
authors.forename: F
authors.initials: F
authors.lastname: Kokot
mesh_terms: D003131:Combined Modality Therapy / Q000592:standards; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D004041:Dietary Fats / Q000008:administration & dosage* / Q000592:standards; D005060:Europe; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000628:therapy; D006949:Hyperlipidemias / Q000150:complications / Q000628:therapy*; D006954:Hyperlipoproteinemia Type V / Q000150:complications / Q000628:therapy; D015228:Hypertriglyceridemia / Q000150:complications / Q000628:therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage* / Q000592:standards; D007391:International Cooperation; D009316:National Institutes of Health (U.S.); D011044:Poland; D012307:Risk Factors; D014481:United States
chemical_list: D004041:Dietary Fats; D000960:Hypolipidemic Agents
vernacular_title: Leczenie hiperlipidemii w profilaktyce niedokrwiennej choroby serca. Propozycja unifikacji postepowania lekarskiego. (Cześć I).